VOYA Investment Management
KNTE

VOYA Investment Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

VOYA Investment Management’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,075
Closed -$75.5K – 3034
2023
Q1 		$75.5K Hold
12,075
– – ﹤0.01% 2747
2022
Q4 		$73.7K Hold
12,075
– – ﹤0.01% 2806
2022
Q3 		$144K Buy
12,075
+1,025
+9% +$13.4K ﹤0.01% 2694
2022
Q2 		$139K Buy
+11,050
New +$103K ﹤0.01% 2534
2021
Q4 		– Sell
-9,198
Closed -$212K – 2826
2021
Q3 		$212K Buy
+9,198
New +$200K ﹤0.01% 2543

Other funds holding KNTE

FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VOYA Investment Management's KNTE Position: Q2 2023 in Review

VOYA Investment Management sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2023, closing a stake of 12,075 shares — an estimated $75.5K sold.

VOYA Investment Management first reported a position in KNTE in Q3 2021 and held it in 5 quarters. The position peaked at $212K in Q3 2021. 72 funds tracked by Wall St. Rank hold KNTE as of Q2 2023.

  • VOYA Investment Management reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • VOYA Investment Management sold 12,075 Kinnate Biopharma Inc. Common Stock shares in Q2 2023, an estimated $75.5K.
  • VOYA Investment Management first reported a position in Kinnate Biopharma Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • VOYA Investment Management's Kinnate Biopharma Inc. Common Stock position peaked at $212K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2023.

Based on VOYA Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.